ALB and chronic myelogenous leukemia, BCR-ABL1 positive: Glycation of HSA significantly increased its binding to RAGE, with HSA–MGO showing the highest binding (20–40%) in a dose-response manner, followed by glucose (15–20%) and CML (15–20%) (Figure 3A).